Abstract:With high prevalence of type 2 diabetes worldwide, diabetic complications have been a major health problem, which reduce life quality and induce premature death in adults. The prevalence of type 2 diabetes is closely related to obesity and aging, two major risk factors for metabolic disorders. The diabetic complications, including retinopathy, nephropathy, neuropathy, skin ulcer, and atherosclerosis, are risk factors for mortality of patients. Retinopathy, nephropathy, and skin ulcer are representatives of microvascular complications, which often happen in insulin-deficient diabetic conditions, such as type 1 diabetic patients and some late-stage type 2 diabetic patients when β-cells completely lose function. Atherosclerosis that is often found in type 2 diabetes is a complication of macrovascular disease that increases the risk for myocardial infarction and strokes. However, atherosclerosis is receiving more and more appreciation in type 1 diabetes. Endothelial cells that line the inner vessel have been extensively studied in the mechanism of the diabetic complications. Impaired endothelial cell function is a common cellular mechanism for most of the diabetic complications (retinopathy, nephropathy, skin ulcer, and atherosclerosis). The cells are exposed to the high level of glucose in diabetic condition and subjected to glucose-induced stresses. The stress may cause overproliferation and deficiency in proliferation of endothelial cells, which contribute to dysfunction of microcirculation. Prevention and treatment of the complications are dependent on protection of the endothelial cell functions in most cases. In this issue, the mechanism of endothelial cell dysfunction was investigated in several studies to understand the molecular events by which the endothelial cells are impaired by hyperglycemia. This topic is enhanced with another group of studies about intervention of the endothelial complications with antioxidant compounds and new drug candidates. These studies will help readers to understand the current status and gain new insights into the diabetic complications. Weiping Jia Aimin Xu Alex Chen Jiarui Wu Jianping Ye

Cellular Senescence: A Bridge Between Diabetes and Microangiopathy

Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells.

High Glucose And Free Fatty Acids Induce Endothelial Progenitor Cell Senescence Via Pgc-1 Alpha/Sirt1 Signaling Pathway

To target cellular senescence in diabetic kidney disease: the known and the unknown

Endothelial Cell Senescence Contributes to Pathological Retinal Angiogenesis

Regulation of Cellular Senescence in Type 2 Diabetes Mellitus: From Mechanisms to Clinical Applications

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity

The Signaling of Cellular Senescence in Diabetic Nephropathy

Mapping cellular senescence networks in human diabetic foot ulcers

Chronic Vascular Complications in Diabetes

Cellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy

Targeting senescence to prevent diabetic kidney disease: Exploring molecular mechanisms and potential therapeutic targets for disease management

Understanding the Intricacies of Cellular Senescence in Atherosclerosis: Mechanisms and Therapeutic Implications

From Macro- to Micro-Vasculature and Its Implications on Cardiovascular Health

The role of cellular senescence in diabetes mellitus and osteoporosis: molecular pathways and potential interventions

Advances in Relationship Between Cell Senescence and Atherosclerosis.

Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications

MicroRNAs in diabetic macroangiopathy

Mitochondrial regulation of diabetic endothelial dysfunction: Pathophysiological links

Cellular Senescence: Mechanisms and Therapeutic Potential

Identification of Senescence-Associated Biomarkers in Diabetic Glomerulopathy Using Integrated Bioinformatics Analysis